ACHE and early-onset autosomal dominant Alzheimer disease: The dual inhibition of acetylcholinesterase and butyrylcholinesterase is beneficial for Alzheimer’s disease patients, especially since butyrylcholinesterase replaces acetylcholinesterase in the acetyl choline catabolism in advanced Alzheimer’s disease patients [26].